134 related articles for article (PubMed ID: 3147639)
1. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
Haissaguerre M; Warin JF; Goldrach S; Le Métayer P; Guillem JP; Blanchot P
Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
6. [Value of intravenous flecainide in electro-induced supraventricular arrhythmia. Apropos of 37 cases].
Graux P; Mekerke W; Lemaire N; Jacquemart T; Durieu-Ghis C; Rihani R; Cornaert P; Dutoit A; Croccel L
Ann Cardiol Angeiol (Paris); 1992 Jan; 41(1):47-52. PubMed ID: 1558365
[TBL] [Abstract][Full Text] [Related]
7. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
[TBL] [Abstract][Full Text] [Related]
8. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
Song Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
[TBL] [Abstract][Full Text] [Related]
9. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
[TBL] [Abstract][Full Text] [Related]
11. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiologic effect of intravenous propafenone in supraventricular tachycardia].
Iturralde P; Nunura F; Romero L; Colín L; Rosado J; Galván O; de Micheli A; González Hermosillo JA; Casanova JM
Arch Inst Cardiol Mex; 1991; 61(2):135-41. PubMed ID: 1854228
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
14. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
[TBL] [Abstract][Full Text] [Related]
17. Tachycardia cycle length and maximum capacity of anterograde and retrograde atrioventricular conduction in paroxysmal supraventricular tachycardia.
Sadr-Ameli MA; Lacombe P; Fromer M; Nadeau R; Shenasa M
Can J Cardiol; 1988 Apr; 4(3):134-9. PubMed ID: 3378196
[TBL] [Abstract][Full Text] [Related]
18. Depressant effect on the retrograde atrioventricular nodal conduction of beta-adrenergic blockade by propranolol in humans.
Shenasa M; Lacombe P; Côté MA; Sadr-Ameli MA; Nadeau R
Can J Cardiol; 1987 Sep; 3(6):281-7. PubMed ID: 3427528
[TBL] [Abstract][Full Text] [Related]
19. [Wolff-Parkinson-White syndrome. Value of intravenous flecainide for detecting Kent's pathways with short refractory period].
Talard P; Cointe R; Bru P; Moyal C; Lacombe P; Bremondy M; Levy S; Gerard R
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):489-92. PubMed ID: 2111669
[TBL] [Abstract][Full Text] [Related]
20. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
